Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/2001
03/15/2001CA2383788A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby
03/15/2001CA2383776A1 Method for generating immune-compatible cells and tissues using nuclear transfer techniques
03/15/2001CA2383774A1 Fibroblast growth factor-like polypeptides
03/15/2001CA2383419A1 Determination of am-binding proteins and the association of adrenomedullin (am) therewith
03/15/2001CA2383186A1 Method to identify gene function using small molecule probes
03/15/2001CA2382729A1 29 human cancer associated proteins
03/15/2001CA2382161A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies
03/15/2001CA2382147A1 Mixing chamber
03/15/2001CA2349434A1 Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases
03/15/2001CA2348657A1 Cloning, expression and characterisation of the spg4 gene responsible for the most frequent form of autosomal spastic paraplegia
03/15/2001CA2346906A1 Systems for sensing red blood cell hematocrit
03/14/2001EP1083428A2 Method and reagent for the detection or determination of HCV core antigens
03/14/2001EP1083426A2 Housing for a sensor
03/14/2001EP1083425A2 Method and device for on-line controlling green tire manufacturing components
03/14/2001EP1083258A1 Hydrophilic fiber
03/14/2001EP1083235A2 Reduced coenzyme solution
03/14/2001EP1083224A2 Apoptin-associating protein
03/14/2001EP1082998A2 Specimen collection assembly with cap
03/14/2001EP1082940A1 Iontophoresis device structural body and method for detecting in-vivo component
03/14/2001EP1082615A1 Immunoassay for quantitative determination of prostate specific antigen (psa) free and complexed with alpha1-antichymotrypsin or alpha1-protease inhibitor
03/14/2001EP1082614A1 Method and device for detecting analytes in fluids
03/14/2001EP1082613A1 Method for detecting analytes
03/14/2001EP1082611A1 Method for staining biological specimens by combining unstable reagents on a microscope slide
03/14/2001EP1082610A1 Method for marking liquids with at least two marker substances and method for detecting them
03/14/2001EP1082607A1 Surface regeneration of biosensors
03/14/2001EP1082597A1 Method and device for determining the compression factor of powders
03/14/2001EP1082489A1 Method for determining the detaching angle and/or the detaching profile of a paper web
03/14/2001EP1082464A1 Method for determining antigens
03/14/2001EP1082460A1 A novel method of diagnosing, monitoring, and staging prostate cancer
03/14/2001EP1082459A1 A novel method of diagnosing, monitoring, and staging lung cancer
03/14/2001EP1082458A1 Method of determining the nucleotide sequence of oligonucleotides and dna molecules
03/14/2001EP1082452A1 Transition state binding assay
03/14/2001EP1082451A2 Method for determining antibiotics with beta-lactam core in a biological fluid
03/14/2001EP1082441A1 Mycobacterial n-acetyltransferases
03/14/2001EP1082435A2 Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
03/14/2001EP1082433A1 Interleukins-21 and 22
03/14/2001EP1082432A2 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
03/14/2001EP1082426A2 Human socs proteins
03/14/2001EP1082423A1 Cyclin e2 genes and proteins
03/14/2001EP1082422A2 Polypeptides from creb binding protein and related protein p300 for use in transcriptional regulation
03/14/2001EP1082416A2 Poly(adp-ribose)polymerase gene
03/14/2001EP1082413A2 Aav5 vector and uses thereof
03/14/2001EP1082344A2 Glycoproteins having lipid mobilising properties and therapeutic applications thereof
03/14/2001EP1082343A2 Toxoplasma gondii antigens, p35, and uses thereof
03/14/2001EP1082341A2 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
03/14/2001EP1082335A1 Novel secreted and membrane-associated proteins and uses therefor
03/14/2001EP1082334A1 Alg-2lp, alg-2 like molecules and uses therefor
03/14/2001EP1082297A1 Substituted dithio-bis-nitrobenzenes and their applications
03/14/2001EP1082289A1 Methods for identifying novel multimeric agents that modulate receptors
03/14/2001EP1082176A1 Centrifugal separation apparatus and method for separating fluid components
03/14/2001EP1082136A1 The cytokine family member, 2-19
03/14/2001EP0975427B1 A device for performing an assay, use of a membrane in the manufacture of said device, kit comprising said device and method for the detection of an analyte using such device.
03/14/2001EP0925504B1 Method for detecting and/or quantifying a gliotoxic factor
03/14/2001EP0906567B1 Process to eliminate haemoglobin errors during the determination of albumin
03/14/2001EP0877924A4 Method for determining feed quality
03/14/2001EP0843820B1 Elisa serodiagnosis of pig pleuropneumonia serotypes 1, 9 and 11
03/14/2001EP0808203B1 Centrifuge with annular filter
03/14/2001EP0771286B1 Apparatus and continuous process for making coagulation assay device
03/14/2001CN2423585Y Glass carrier sheet
03/14/2001CN1287689A Affinity based self-assembly systems and devices for photonic and electronic applications
03/14/2001CN1287617A Blood measuring instrument
03/14/2001CN1287615A Method of preparing slag sample for x-ray fluorescence analysis and sampler
03/14/2001CN1287269A Analytical system of closing indoor atmosphere with alloy soldering or during tinplating
03/13/2001US6201885 Method for bakery product measurement
03/13/2001US6201165 Drug screening by contacting isolated cardiomyocyte having calcineurin, calcium calmodulin dependent kinase iv or ii alpha, p38, or mkk6 transgene with compound; measuring physiological parameter; and comparing to control
03/13/2001US6201141 Determination of steroids by competitive immunoassay
03/13/2001US6201134 Diaminorhodamine derivatives
03/13/2001US6201116 Halide indicators
03/13/2001US6201111 Methods for treating subjects with disorders characterized by expression of tumor rejection antigen precursors
03/13/2001US6201108 Antibodies which bind to mammalian transforming growth factor-beta type ii receptor; treatment of bone disorders; anticarcinogenic/antimetastasis agents
03/13/2001US6201106 Cytokine signal regulators
03/13/2001US6201105 Amino acid sequence; treatment of septic shock and cachexia; diagnosis
03/13/2001US6201104 Amino acid sequences of angiogenesis-inhibiting protein receptor; drug screening; isolation of angiogenesis related proteins
03/13/2001US6201086 Electrically conductive electroactive functionalized conjugated polymers, and uses thereof
03/13/2001US6200951 For detecting chitin, binding chitin, and treating fungal infections or for development of products useful for fungal infection therapy
03/13/2001US6200820 Light scatter-based immunoassay
03/13/2001US6200819 For controlling dilution of exhaust gas sample from automobile engine; uses system of critical flow orifices at a predetermined and precisely controlled flow ratio
03/13/2001US6200817 Analyzing sample of fluid for presence of clue cells by applying to solid alkali and gas-permeable indicator lamina impregnated with indicator that changes color upon contact with amines
03/13/2001US6200816 Method for measuring particulate and gaseous metals in a fluid stream, device for measuring particulate and gaseous metals in a fluid stream
03/13/2001US6200815 Accurate measurement by establishing potential across volume, passing suspension through volume, continously measuring potential, comparing to baseline, then calculating total volume of solids; diagnosis using blood
03/13/2001US6200805 Human cell line cloned from cell which has been stably transformed by recombinant vector having reporter gene linked to human interleukin-4-repsonsive element
03/13/2001US6200787 Phenylalanyl tRNA synthetase polypeptides from streptococcus pneumoniae
03/13/2001US6200780 Human interferon-ε(IFN-ε), a type I interferon
03/13/2001US6200777 Human p101 polynucleotides
03/13/2001US6200776 Polynucleotides encoding human sodium bicarbonate cotransporters
03/13/2001US6200774 Compounds
03/13/2001US6200773 Diagnostics based on tetrazolium compounds
03/13/2001US6200771 Determination cyclooxygenase inhibition and phosphodiesteraseinhibition; calibration
03/13/2001US6200770 Protein kinase molecules and uses therefor
03/13/2001US6200769 Mammalian CDP-diacylglycerol synthase
03/13/2001US6200768 Detecting compounds efficient in the dissolution of an alzheimer's protein; incubate preferential protein with kinase, monitor helix formation, incubate with modulator and detect blocking action by modulator
03/13/2001US6200766 Methods and reagents for quantitation of HLA-DR expression on peripheral blood cells
03/13/2001US6200765 Diagnosing tumors in humans; determine the ratio of prostate gland tissue and a random tissue in sample, amplified amount of prostate tissues in sample indicates, tumors
03/13/2001US6200764 Monitoring activated g-protein in a bodily fluid; incubating bodily fluid with an immobilized monocolnal antibody, screen for signal in sample
03/13/2001US6200763 Detecting cell expressing myeloid polypeptide; incubate cell with binding substance and detecting bound substance, presence of bound protein indicates cell expressing myeloid protein
03/13/2001US6200762 Photon reducing agents and compositions for fluorescence assays
03/13/2001US6200759 Interaction trap assay, reagents and uses thereof
03/13/2001US6200749 Ajusted nucleic acid sequence; for detection of genome adjustments and preferential genetic disorders
03/13/2001US6200746 Detection of enzyme inhibitor; evaluate kinase phosphorylation in presence and absence of virus, incubate with test compound, monitor decrease in enzyme activity
03/13/2001US6200745 Vitro assay system using a human cell line for testing the effectiveness of anti-papilloma viral agents